StockNews.com Begins Coverage on Cyclacel Pharmaceuticals (NASDAQ:CYCC)
Analysts at StockNews.com assumed coverage on shares of Cyclacel Pharmaceuticals (NASDAQ:CYCC – Get Free Report) in a research note issued on Thursday. The firm set a “sell” rating on the biotechnology company’s stock. Cyclacel Pharmaceuticals Trading Up 0.6 % Shares of Cyclacel Pharmaceuticals stock opened at $0.32 on Thursday. The firm has a market cap […]
Analysts at StockNews.com assumed coverage on shares of Cyclacel Pharmaceuticals (NASDAQ:CYCC – Get Free Report) in a research note issued on Thursday. The firm set a “sell” rating on the biotechnology company’s stock. Cyclacel Pharmaceuticals Trading Up 0.6 % Shares of Cyclacel Pharmaceuticals stock opened at $0.32 on Thursday. The firm has a market cap […]
